Increasing numbers of clinical studies have shown that increased circulating RBP4 are not only correlated with established cardiovascular risk factors such as obesity and dyslipidemia, but also correlated with the prevalence of atherosclerotic diseases and CAD [16]. The gene discussed is RBP4; the disease is metabolic syndrome.